Regulation of p53 in response to DNA damage
The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Abstract
Activation of p53 can occur in response to a number of cellular stresses, including DNA damage, hypoxia and nucleotide deprivation. Several forms of DNA damage have been shown to activate p53, including those generated by ionising radiation (IR), radio-mimetic drugs, ultraviolet light (UV) and chemicals such as methyl methane sulfonate (MMS). Under normal conditions, p53 levels are maintained at a low state by virtue of the extremely short-half life of the polypeptide. In addition to this, p53 normally exists in an largely inactive state that is relatively inefficient at binding to DNA and activating transcription. Activation of p53 in response to DNA damage is associated with a rapid increase in its levels and with an increased ability of p53 to bind DNA and mediate transcriptional activation. This then leads to the activation of a number of genes whose products trigger cell-cycle arrest, apoptosis, or DNA repair. Recent work has suggested that this regulation is brought about largely through DNA damage triggering a series of phosphorylation, de-phosphorylation and acetylation events on the p53 polypeptide. Here, we discuss the nature of these modifications, the enzymes that bring them about, and how changes in p53 modification lead to p53 activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“UV-induced phosphorylation at Serine 15 increased p53 stability and protein level that associated with DNA damage [61].”
From Ultraviolet Radiation‐Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin Aging (2016) · cites this paper as [61]
In the citing paper
“Under normal conditions, cellular p53 protein levels are very low owing to strict control by its negative regulators MDM2 and MDMX, which promote p53 degradation through ubiquitination.27,28”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [28]
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 1×
“Notably, several recent reports have provided data consistent with a model in which Mdm2 interacts with p53 in undamaged cells and targets it for ubiquitin-mediated degradation (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997; Fuchs et al., 1998).”
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 4,296
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“Notably, several recent reports have provided data consistent with a model in which Mdm2 interacts with p53 in undamaged cells and targets it for ubiquitin-mediated degradation (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997; Fuchs et al., 1998).”
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113 · cited 2×
“Interaction of Mdm2 with this N-terminal region of p53 has been demonstrated to inhibit the ability of p53 to activate transcription (Momand et al., 1992; Oliner et al., 1993).”
BackgroundKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 1×
“Initial clues suggesting that ATM may be involved in regulation of p53 in response to DNA damage came from observations that cell cycle checkpoint controls and up-regulation of p53 in response to IR are defective in A-T cells (Kastan et al., 1992; Khanna and Lavin, 1993; Canman et al., 1994).”
BackgroundHistone acetylation in chromatin structure and transcription
Grunstein, M. (1997) · Nature · doi:10.1038/38664 · Cited by 2,884 · cited 1×
“Further support for this idea has been provided by the demonstration that certain histone acetyl-transferase (HAT) enzymes correspond to key transcriptional coactivators, such as CBP/p300 and PCAF (for reviews see Grunstein, 1997; Kouzarides, 1999).”
BackgroundA Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785 · cited 1×
“The gene mutated in ataxia-telangiectasia patients was mapped to human chromosome 11q2223, and the gene, termed ATM, has been cloned (Gatti et al., 1988; Savitsky et al., 1995).”
BackgroundActivation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559 · cited 2×
“Thus, in addition to potentially playing a role in acetylating histones at p53-dependent promoters, CBP/p300 has been shown to be able to acetylate p53 at lysine-373 and lysine-382, whilst PCAF can acetylate p53 at lysine-320 (Gu and Roeder, 1997; Sakaguchi, 1998; Liu et al., 1999).”
BackgroundKo, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344 · cited 4×
“Elevated levels of p21 then inhibit the cyclin E/cdk2 and cyclin A/cdk2 kinases, thus preventing these kinases from promoting cell cycle progression (for review, see Ko and Prives, 1996; Levine, 1997).”
BackgroundInfluential
Research works printed but not linked: 3
- Lakin ND, Hann BC and Jackson SP. . 1999 Oncogene in press.
- Lees-Miller SP, Sakaguchi K, Ullrich SJ, Appella E and Anderson CW. . 1992 Mol. Cell. Biol. 12: 5041–5049. · doi:10.1128/mcb.12.11.5041-5049.1992 · Paper page
- Maltzman W and Czyzyk L. . 1984 Mol. Cell. Biol. 4: 1689–1694. · DOI · Paper page
Cited by
Items 401–500 of 1,000
Takeba, Y., Sekine, S., Kumai, T., Matsumoto, N., Nakaya, S., Tsuzuki, Y., Yanagida, Y., Nakano, H., Asakura, T., Ohtsubo, T., et al. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.1400 · Cited by 38
Nakazawa, Y., Kamijo, T., Koike, K., & Noda, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300510200 · Cited by 43
Li, W.-H., Wang, F., Song, G.-Y., Yu, Q., Du, R.-P., & Xu, P. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1198948 · Cited by 44
Akt3 is responsible for the survival and proliferation of embryonic stem cells
Wang, L., Huang, D., Jiang, Z., Luo, Y., Norris, C. E., Zhang, M., Tian, X., & Tang, Y. (2017) · Biology Open · doi:10.1242/bio.024505 · Cited by 43
“p53 plays a central role in response to DNA damage repair resulting in cell growth arrest and apoptosis (Lakin and Jackson, 1999; Meek, 2009; Sakaguchi et al., 1998; Smith and Seo, 2002).”
BackgroundRegulation of the cell cycle and centrosome biology by deubiquitylases
Darling, S., Fielding, A. B., Sabat‐Pośpiech, D., Prior, I. A., & Coulson, J. M. (2017) · Biochemical Society Transactions · doi:10.1042/bst20170087 · Cited by 42
“transcription of p53 target genes (21), as well as activating transcription-independent roles of p53 in many of the major DDR pathways (22).”
Backgroundp53 and ATM/ATR Regulate 7,12-Dimethylbenz[a]anthracene-Induced Immunosuppression
Gao, J., Mitchell, L., Lauer, F. T., & Burchiel, S. W. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.039230 · Cited by 47
“A key sensor responsible for DNA damage is p53, a tumor suppressive protein whose loss of function leads to tumor development (Lakin and Jackson, 1999). p53 expression is normally constitutively expressed at low levels in mammalian cells, with a short half-life being regulated by the mouse double…”
BackgroundCell Cycle Regulation of Human Endometrial Stromal Cells During Decidualization
Logan, P. C., STEINER, M. C., Ponnampalam, A. P., & Mitchell, M. D. (2012) · Reproductive Sciences · doi:10.1177/1933719112438447 · Cited by 46
Xie, D., Lan, L., Huang, K., Chen, L., Xu, C., Wang, R., Shi, Y., Wu, X., Wang, L., Liu, Y., et al. (2014) · Oncology Reports · doi:10.3892/or.2014.3538 · Cited by 37
“Under normal conditions, p53 protein levels in cells are maintained at very low levels due to extremely short half-life, and p53 is largely inactive, unless the cells are activated by signals from DNA damage and a number of other cellular stress factors, including hypoxia and nucleotide deprivation (15,23).”
BackgroundPOSPÍŠILOVÁ, Š., BRÁZDA, V., KUCHAŘÍKOVÁ, K., LUCIANI, M. G., HUPP, T. R., SKLÁDAL, P., PALEČEK, E., & VOJTĚŠEK, B. (2004) · Biochemical Journal · doi:10.1042/bj20030662 · Cited by 38
“The p53 tumour suppressor protein (reviewed in [ 1 ,2]) is a potent transcription factor, playing a key role in cell cycle regulation and differentiation.”
BackgroundHall, A. E., Lu, W.-T., Godfrey, J. D., Antonov, A. V., Paicu, C., Moxon, S., Dalmay, T., Wilczynska, A., Muller, P. A. J., & Bushell, M. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.91 · Cited by 43
“This induces the transcription of genes whose products trigger cell-cycle arrest, DNA repair or apoptosis.(7) More recently, p53 has been shown to regulate certain microRNAs (miRNA) by facilitating their transcription or modulating the activity of the miRNA biogenesis machinery.”
BackgroundGuardian ancestry: fly p53 and damage-inducible apoptosis
Nordstrom, W., & Abrams, J. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400766 · Cited by 44
Latonen, L., Kurki, S., Pitkänen, K., & Laiho, M. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00044-x · Cited by 39
Gene and microRNA expression in p53‐deficient day 8.5 mouse embryos
Hosako, H., Martin, G. S., Barrier, M., Chen, Y. A., Ivanov, I. V., & Mirkes, P. E. (2009) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20565 · Cited by 40
Kobayashi, G., Sentani, K., Babasaki, T., Sekino, Y., Shigematsu, Y., Hayashi, T., Oue, N., Teishima, J., Matsubara, A., Sasaki, N., et al. (2020) · Cancer Science · doi:10.1111/cas.14299 · Cited by 36
DNA repair in cardiomyocytes is critical for maintaining cardiac function in mice
de Boer, M., Hekkert, M. T. L., Chang, J., van Thiel, B. S., Martens, L., Bos, M. M., de Kleijnen, M. G. J., Ridwan, Y. R., Octavia, Y., van Deel, E. D., et al. (2023) · Aging Cell · doi:10.1111/acel.13768 · Cited by 37
“TP53 is known to trigger cell- cycle arrest, apoptosis or DNA repair in response to DNA damage and thereby activates specific genes (Lakin & Jackson, 1999).”
BackgroundDas, K. C., Ravi, D., & Holland, W. S. (2004) · Antioxidants and Redox Signaling · doi:10.1089/152308604771978417 · Cited by 36
“Phosphorylation of p53 at Ser 15 residue dissociates MDM2 (mitotic arrest-deficient yeast homologue) and activates p53 as a transcription factor; binding of this activated factor to various p53-dependent genes results in activation or repression (21).”
Checkpoint and DNA-repair proteins are associated with the cores of mammalian meiotic chromosomes
Tarsounas, M., & Møens, P. B. (2001) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(01)51004-2 · Cited by 37
Pasumarthi, K. B. S., Tsai, S.-C., & Field, L. J. (2001) · Circulation Research · doi:10.1161/hh1001.090878 · Cited by 36
Cyclizing-berberine A35 induces G2/M arrest and apoptosis by activating YAP phosphorylation (Ser127)
Zhao, W., Liu, H., Wang, J., Wang, M., & Shao, R. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0759-6 · Cited by 35
“Our results showed that p53 was not involved in G2/ M arrest or apoptosis, even though it has been shown to be an essential inducer of G2/M arrest and apoptosis in response to DNA damage [40].”
Chen, Y.-C., Young, M.-J., Chang, H.-P., Liu, C.-Y., Lee, C.-C., Tseng, Y., Wang, Y., Chang, W., & Hung, J. (2022) · Oncogenesis · doi:10.1038/s41389-022-00397-4 · Cited by 38
“TP53 is an important tumor suppressor gene that is involved in cell proliferation and metastasis through various mechanisms, such as the cell cycle and DNA damage repair [4, 5].”
BackgroundLoss of HSF1 Results in Defective Radiation-Induced G2Arrest and DNA Repair
Li, Q., & Martinez, J. D. (2011) · Radiation Research · doi:10.1667/rr2393.1 · Cited by 36
Vilasová, Z., Řezáčová, M., Vávrová, J., Tichý, A., Vokurková, D., Zölzer, F., Řeháková, Z., Österreicher, J., & Lukášová, E. (2008) · Acta Biochimica Polonica · doi:10.18388/abp.2008_3086 · Cited by 35
NAKAMURA, H., FUKAMI, H., HAYASHI, Y., KIYONO, T., NAKATSUGAWA, S., HAMAGUCHI, M., & ISHIZAKI, K. (2002) · Journal of Radiation Research · doi:10.1269/jrr.43.167 · Cited by 35
Bruins, W., Bruning, O., Jonker, M. J., Zwart, E., van der Hoeven, T. V., Pennings, J. L. A., Rauwerda, H., de Vries, A., & Breit, T. M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01610-07 · Cited by 38
Nitric oxide induces oral squamous cell carcinoma cells apoptosis with p53 accumulation
Shi-fang, Z., Tong, X.-Y., & Zhu, F. (2005) · Oral Oncology · doi:10.1016/j.oraloncology.2005.04.002 · Cited by 37
Okuno, T., Matsuoka, M., Sumizawa, T., & Igisu, H. (2005) · Archives of Toxicology · doi:10.1007/s00204-005-0022-8 · Cited by 36
“The phosphorylation takes place in the p53 protein molecule on multiple residues in both the amino- and carboxy-terminal domains (Giaccia and Kastan 1998; Lakin and Jackson 1999; Meek 1998).”
BackgroundRamachandhiran, D., Sankaranarayanan, C., Murali, R., Babukumar, S., & Vinothkumar, V. (2019) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2019.1669057 · Cited by 36
“It is a key factor in maintaining the balance between cell growth and death (Lakin and Jackson 1999).”
BackgroundGenetic Variants and Oxidative Stress in Alzheimer’s Disease
Kowalska, M., Wize, K., Prendecki, M., Lianeri, M., Kozubski, W. P., & Dorszewska, J. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200224121447 · Cited by 36
Zema, S., Pelullo, M., Nardozza, F., Felli, M. P., Screpanti, I., & Bellavia, D. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.613557 · Cited by 34
“…MAML1 regulation may improve the therapeutic approach in muscular dystrophies. p53 p53 is a tumor suppressor involved in cell responses to genotoxic stresses through the modulation of cell cycle, apoptosis and senescence expression genes (Lakin and Jackson, 1999; Vousden and Lu, 2002; Dimri, 2005).”
BackgroundValentijn, F. A., Knoppert, S. N., Pissas, G., Rodrigues-Díez, R. R., Márquez‐Expósito, L., Broekhuizen, R., Mokrý, M., Kester, L. A., Falke, L. L., Goldschmeding, R., et al. (2021) · Antioxidants · doi:10.3390/antiox10122020 · Cited by 35
“Oxidative stress in IRI involves excessive ROS production, driving DNA damage and a DDR involving p53 pathway’s activation [8,40,41].”
BackgroundKiyonari, S., Iimori, M., Matsuoka, K., Watanabe, S., Morikawa, T., Miura, D., Niimi, S., Saeki, H., Tokunaga, E., Oki, E., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0748 · Cited by 34
“Because p-p53(S15) weakens the p53–MDM2 interaction and contributes to p53 accumulation by inhibiting MDM2-mediated p53 degradation (28) and nutlin-3a also induced p53-mediated repression of DUT-N expression without p-p53(S15) (Fig.”
Chen, C., Tai, C.-J., Cheng, J., Zheng, J.-J., Chen, Y.-Z., Liu, T., Yiin, S.-J., & Chern, C. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf904260b · Cited by 34
The accumulation of DNA repair defects is the molecular origin of carcinogenesis
Cha, H., & Yim, H. (2013) · Tumor Biology · doi:10.1007/s13277-013-1038-y · Cited by 39
“As described above, ATM is activated in response of DSB and triggers tumor suppressor p53 [83–86].”
BackgroundZaman, S., Yu, X., Bencivenga, A. F., Blanden, A. R., Liu, Y., Withers, T., Na, B., Blayney, A. J., Gilleran, J., Boothman, D. A., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-1080 · Cited by 35
“These kinases induce posttranslational modifications (PTM) that stabilize the protein and augment recruitment of the transcriptional machinery and inmany cases induce an apoptotic program (3).”
BackgroundLu, Y., Lian, H., Sharma, P., Schreiber‐Agus, N., Russell, R. G., Chin, L., van der Horst, G. T. J., & Bregman, D. B. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1810-1818.2001 · Cited by 35
“It has been shown that CSB gene disruption leads to p53 induction (increased steady-state level) at lower doses of UVC radiation than in WT cells, presumably because the CSB-deficient cells cannot clear stalled RNA polymerase II from UVC-induced lesions, which appear to stimulate p53 induction (35, 41).”
BackgroundKobayashi, K., & Tsukamoto, I. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00059-x · Cited by 36
Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia
Zavras, P. D., Sinanidis, I., Tsakiroglou, P., & Karantanos, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24055018 · Cited by 37
“TP53 is a tumor-suppressor gene located on the short arm of chromosome 17 and encodes transcription factor P53, which is critical for cell-cycle arrest, DNA repair and apoptosis in the setting of DNA damage [90].”
BackgroundThe role of cyclin D1 in response to long-term exposure to ionizing radiation
Shimura, T., Fukumoto, M., & Kunugita, N. (2013) · Cell Cycle · doi:10.4161/cc.25746 · Cited by 38
Time‐series transcriptomics and proteomics reveal alternative modes to decode p53 oscillations
Jiménez, A., Lu, D., Kalocsay, M., Berberich, M. J., Balbi, P., Jambhekar, A., & Lahav, G. (2022) · Molecular Systems Biology · doi:10.15252/msb.202110588 · Cited by 36
Hallmarks of cancer: The insulin-like growth factors perspective
Werner, H., & LeRoith, D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1055589 · Cited by 33
“The ubiquitin ligase Mdm2 is of major importance in regulation of p53 activity (114) and IGF1 was shown to induce p53 degradation in an Mdm2dependent manner (115).”
BackgroundSharifi‐Sistani, N., Zartab, H., Babakoohi, S., Saghravanian, N., Jamshidi, S., Esmaily, H., Mohtasham, N., Zamanzadeh, M., & Abbaszadeh, H. (2011) · Journal of Craniofacial Surgery · doi:10.1097/scs.0b013e31823188e9 · Cited by 33
“P53 is activated in cellular stresses including DNA damage, hypoxia, and nucleotide deprivation.(5) In more than half of all tumors, there is a complete loss of function in p53 due to a point mutation on 1 allele coupled with a complete inactivation of the other allele.”
BackgroundThe role of MDM2 in the proliferative activity of ameloblastoma
Sandra, F., Nakamura, N., Kanematsu, T., Hirata, M., & Ohishi, M. (2002) · Oral Oncology · doi:10.1016/s1368-8375(01)00036-7 · Cited by 33
“The p53 protein, a most intensively studied protein in oncology and a potent inhibitor of cell growth, is responsible for arresting the cell cycle at several distinct points, as well as inactivating the apoptotic machinery leading to cell death in some circumstances [5–7].”
BackgroundJin, X., Moskophidis, D., Hu, Y., Phillips, A. C., & Mivechi, N. F. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22151 · Cited by 35
Pan, H., Wang, F., Rankin, G. O., Rojanasakul, Y., Tu, Y., & Chen, Y. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4145 · Cited by 32
“The cell cycle can be held at the G1 regulation point on DNA damage recognition (21).”
Reactivation of Epstein-Barr Virus by HIF-1α Requires p53
Kraus, R. J., Cordes, B.-L. A., Sathiamoorthi, S., Patel, P., Yuan, X., Iempridee, T., Yu, X., Lee, D. L., Lambert, P. F., & Mertz, J. E. (2020) · Journal of Virology · doi:10.1128/jvi.00722-20 · Cited by 35
Weyerer, V., Strissel, P. L., Stöhr, C., Eckstein, M., Wach, S., Taubert, H. W., Brandl, L., Geppert, C. I., Wullich, B., Cynis, H., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.657187 · Cited by 32
“In addition to DNA demethylation via DNMT inhibition, Aza treatment of cells increased p53, activation of p21 and a cell cycle arrest due to DNA damage (62, 63).”
BackgroundThyroid hormone-dependent regulation of metabolism and heart regeneration
Ross, I., Omengan, D. B., Huang, G. N., & Payumo, A. Y. (2021) · Journal of Endocrinology · doi:10.1530/joe-21-0335 · Cited by 38
“The activation of the DDR signaling pathway as a result of increased ROS production was shown to promote the production of p53 and p21, both of which had been associated with inhibition of cell cycle progression (Lakin & Jackson 1999).”
BackgroundDouble-strand break toxicity is chromatin context independent
Friskes, A., Koob, L., Krenning, L., Severson, T., Koeleman, E. S., Vergara, X., Schubert, M., van den Berg, J., Evers, B., Manjón, A. G., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac758 · Cited by 32
“This indicates that DSBs induced by these sgRNAs effectively suppressed cell proliferation in a p53-dependent manner, which is consistent with the established role of p53 in the DNA damage response (23,41).”
ResultThe urine proteome as a biomarker of radiation injury
Sharma, M., Halligan, B. D., Wakim, B. T., Savin, V. J., Cohen, E. P., & Moulder, J. E. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200780153 · Cited by 32
“We speculated that TBI-induced injury may result in excretion of modified proteins in the urine [32,33].”
BackgroundRao, V. A., & Plunkett, W. K. (2003) · PubMed · Cited by 38
Li, D., Jackson, R. A., Yusoff, P., & Guy, G. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.148445 · Cited by 48
Jaceosidin induces p53-dependent G2/M phase arrest in U87 glioblastoma cells.
Khan, M. T., Rasul, A., Yi, F., Zhong, L., & Ma, T. (2011) · PubMed · Cited by 32
Zuco, V., Benedetti, V., Cesare, M. D., & Zunino, F. (2009) · International Journal of Cancer · doi:10.1002/ijc.24819 · Cited by 32
“The state of phosphorylation and acetylation of p53 is known to be crucial in triggering the apoptotic response following genotoxic stress.(17) As shown in Figure 10, ST1926 induced p53 phosphorylation at serine 15 and acetylation at lysine 382 after 4 hr of treatment.”
Backgrounddelta transgenic mouse: A novel approach for molecular dissection of deletion mutations
Nohmi, T., & Masumura, K. (2004) · Advances in Biophysics · doi:10.1016/s0065-227x(04)80106-0 · Cited by 32
Rajavel, T., Priya, G. B., Suryanarayanan, V., Singh, S. K., & Devi, K. P. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.04.051 · Cited by 31
Venit, T., Semesta, K. M., Farrukh, S., Endara-Coll, M., Havalda, R., Hozák, P., & Percipalle, P. (2020) · Communications Biology · doi:10.1038/s42003-020-0836-1 · Cited by 31
Shifting the paradigms for tumor suppression: lessons from the p53 field
Barnoud, T., Indeglia, A., & Murphy, M. E. (2021) · Oncogene · doi:10.1038/s41388-021-01852-z · Cited by 31
Regulation of p53 Function by Formation of Non-Nuclear Heterologous Protein Complexes
Zavileyskiy, L. G., & Bunik, V. I. (2022) · Biomolecules · doi:10.3390/biom12020327 · Cited by 31
“The DNA-binding function is well known to be regulated by the interaction of p53 with a number of nuclear proteins [8,9].”
BackgroundYuan, L., Yu, W., Xu, M., & Qu, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506768200 · Cited by 36
Molecular mechanisms of hydroxyurea(HU)-induced apoptosis in the mouse fetal brain
Woo, G., Bak, E., Nakayama, H., & Doi, K. (2005) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2005.08.002 · Cited by 32
Oh, E., Park, M., Choi, B., Ro, S., Choi, E., Jeong, S., & Park, H. J. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9568-2 · Cited by 34
“p53 is regulated by multiple post-translational modifications, including acetylation, phosphorylation, and ubiquitination at its amino- and carboxyl-terminal regions [20, 21 ].”
BackgroundWu, S., Xu, H., Wu, X., Liu, P., Shi, Y., Pang, P., Deng, L., Zhou, G., & Chen, X. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.152895 · Cited by 32
Mathieu, A., Gonin-Giraud, S., Leverrier, Y., Blanquier, B., Thomas, J., Dantin, C., Martin, G., Baverel, G., & Marvel, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007147200 · Cited by 33
Spatial repression of PCNA by p53 during kidney development
Saifudeen, Z., Marks, J., Du, H., & El-Dahr, S. S. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00114.2002 · Cited by 31
“Among the well-characterized p53 target genes are p21waf1/cip1, GADD45, IGF-BP3, Bax, cyclin G, and PCNA (21, 23, 31, 36, 44).”
Truscott, M., Raynal, L. C., Wang, Y., Bérubé, G., Leduy, L., & Nepveu, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409484200 · Cited by 36
Yamauchi, H., Katayama, K., Ueno, M., Uetsuka, K., Nakayama, H., & Doi, K. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.103.026252 · Cited by 32
“In a lot of cases, the function of p53 is mediated by those posttranscriptional mechanisms increasing the half-life and transcriptional activity of the protein [43, 44].”
Backgroundp53 is dispensable for UV-induced cell cycle arrest at late G1 in mammalian cells
Al-Mohanna, M. A., Al-Khodairy, F. M., Krezolek, Z., Bertilsson, P.-A., Al-Houssein, K. A., & Aboussekhra, A. (2001) · Carcinogenesis · doi:10.1093/carcin/22.4.573 · Cited by 30
Harrison, O., Visan, A. C., Moorjani, N., Modi, A., Salhiyyah, K., Torrens, C., Ohri, S. K., & Cagampang, F. R. A. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.06.008 · Cited by 30
Follow the Mutations: Toward Class-Specific, Small-Molecule Reactivation of p53
Loh, S. N. (2020) · Biomolecules · doi:10.3390/biom10020303 · Cited by 30
“ROS stimulates damage response pathways t at post-translatio ally modify p53 to enhance its nuclear entry, recruitment f transcriptional machinery, and resistance to turnover [55].”
BackgroundHyperoxia causes senescence and increases glycolysis in cultured lung epithelial cells
Scaffa, A., Peterson, A. L., Carr, J. F., Garcia, D., Yao, H., & Dennery, P. A. (2021) · Physiological Reports · doi:10.14814/phy2.14839 · Cited by 34
“A key response to DNA damage is the upregulation of p53 (Lakin & Jackson, 1999; Williams & Schumacher, 2016).”
BackgroundSalech, F., Ponce, D. P., SanMartín, C. D., Rogers, N. K., Chacón, C., Henríquez, M., & Behrens, M. I. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00310 · Cited by 32
“…oxidative death of lymphocytes. p53 is a transcription factor known as the guardian of the genome by its role in sensing DNA damage and inducing DNA repair, or if that is not possible, leading to either cell cycle arrest, apoptosis, or senescence (Lakin and Jackson, 1999; Green and Kroemer, 2009).”
BackgroundEun, K., Park, M. G., Jeong, Y. W., Jeong, Y. I., Hyun, S., Hwang, W. S., Kim, S.-H., & Kim, H. (2019) · BMC Biotechnology · doi:10.1186/s12896-018-0491-5 · Cited by 30
Exploiting aneuploidy-imposed stresses and coping mechanisms to battle cancer
Zhou, L., Jilderda, L. J., & Foijer, F. (2020) · Open Biology · doi:10.1098/rsob.200148 · Cited by 32
IGF-1 activates p21 to inhibit UV-induced cell death
Murray, S. A., Zheng, H., Gu, L., & Xiao, Z. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206327 · Cited by 32
“The tumor suppressor protein p53 plays a central role in response to genotoxic stress resulting in cell cycle arrest or apoptosis (Lakin and Jackson, 1999; Vogelstein et al., 2000; Woods and Vousden, 2001).”
BackgroundHomeostatic Imbalance between Apoptosis and Cell Renewal in the Liver of Premature Aging XpdTTD Mice
Park, J. Y., Cho, M., Leonard, S., Calder, B. R., Mian, S. I., Kim, W., Wijnhoven, S., STEEG, H. V., Mitchell, J. R., van der Horst, G. T. J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002346 · Cited by 33
“damage [22].”
Diverse nuclear transport pathways regulate cell proliferation and oncogenesis
Hood, J. K., & Silver, P. A. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00018-4 · Cited by 36
Phosphorylation of p53 protein in A549 human pulmonary epithelial cells exposed to asbestos fibers.
Matsuoka, M., Igisu, H., & Morimoto, Y. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.5945 · Cited by 32
A spatial physiological model for p53 intracellular dynamics
Dimitrio, L., Clairambault, J., & Natalini, R. (2012) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2012.08.035 · Cited by 31
García-Garrido, E., Cordani, M., & Somoza, Á. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122067 · Cited by 29
Ooi, K. K., Yeo, C. I., Ang, K. P., Akim, A. M., Cheah, Y. K., Halim, S. N. A., Seng, H., & Tiekink, E. R. T. (2015) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-015-1271-5 · Cited by 32
Micali, N., Longobardi, E., Iotti, G., Ferrai, C., Castagnaro, L., Ricciardi, M., Blasi, F., & Crippa, M. P. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq019 · Cited by 29
“Upon etoposide treatment, higher levels of p53 accumulation (21,22) were detected in Prep1-overexpressing F9 cells Figure 2.”
BackgroundRoey, K. V., & Davey, N. E. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0123-9 · Cited by 31
“1f), transitions of cell cycle phase [41, 67–69] or detection of DNA damage [70, 71]).”
BackgroundHOPS/TMUB1 retains p53 in the cytoplasm and sustains p53‐dependent mitochondrial apoptosis
Castelli, M., Piobbico, D., Chiacchiaretta, M., Brunacci, C., Pieroni, S., Bartoli, D., Gargaro, M., Fallarino, F., Puccetti, P., Soddu, S., et al. (2019) · EMBO Reports · doi:10.15252/embr.201948073 · Cited by 31
“p53 is a key mediator of apoptosis in DNA damage response [10,21,29,30].”
Cellular reprogramming in the F 3 mouse with paternal F 0 radiation history
Vance, M. M., Baulch, J. E., Raabe, O. G., Wiley, L. M., & Overstreet, J. W. (2002) · International Journal of Radiation Biology · doi:10.1080/095530002317577330 · Cited by 29
“…from F3 oVspring with and literature regarding cellular response to acute expo- somatic irradiation (Kastan et al. 1991, MacCallum et al. 1996, Lakin and Jackson 1999, and others), butsure to low LET radiation such as c-rays (Woloschak et al. 1990, Wilson et al. 1993, Carter et al. 1998, and…”
BackgroundEffect of cell confluence on ultraviolet light apoptotic responses in DNA repair deficient cells
Carvalho, H., da Costa, R. M. A., Chiganças, V., Weinlich, R., Brumatti, G., Amarante-Mendes, G. P., Sarasin, A. R., & Menck, C. F. M. (2003) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2003.06.004 · Cited by 34
“Upon UV irradiation, cells stall the cell cycle, generally by p53 activation [7,8], to allow the NER system enough time to correct DNA mutations.”
Background4-NQO induces apoptosis via p53-dependent mitochondrial signaling pathway
Han, H., Pan, Q., Zhang, B., Li, J., Deng, X., Lian, Z., & Li, N. (2006) · Toxicology · doi:10.1016/j.tox.2006.11.045 · Cited by 31
Szkanderová, S., Vávrová, J., Řezáčová, M., Vokurková, D., Pavlová, Š., Šmardová, J., & Stulík, J. (2003) · Folia Biologica · doi:10.14712/fb2003049050191 · Cited by 29
Mondal, J., Das, J., Shah, R., & Khuda‐Bukhsh, A. R. (2016) · Journal of Chinese Integrative Medicine · doi:10.1016/s2095-4964(16)60251-0 · Cited by 28
Teixeira, A., DaCunha, D. C., Barros, L., Caires, H. R., Xavier, C. P. R., Ferreira, I. C. F. R., & Vasconcelos, M. H. (2019) · Food & Function · doi:10.1039/c8fo02466a · Cited by 28
Current aspects of DNA damage and repair in ecotoxicology: a mini-review
Costa, P. M. (2021) · Ecotoxicology · doi:10.1007/s10646-021-02487-2 · Cited by 30
WalyEldeen, A. A., El-Shorbagy, H. M., Hassaneen, H. M., Abdelhamid, I. A., Sabet, S., & Ibrahim, S. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02269-5 · Cited by 28
“…that p53 becomes active in response to DNA damage, with its capacity to bind DNA and induce transcriptional activation increasing as its expression levels are rising quickly (Lakin and Jackson 1999). p53 stimulates target genes, resulting in DNA damage repair, cell growth inhibition, and apoptosis.”
BackgroundTranscriptional responses to teflubenzuron exposure in European lobster (Homarus gammarus)
Olsvik, P. A., Samuelsen, O. B., Agnalt, A., & Lunestad, B. T. (2015) · Aquatic Toxicology · doi:10.1016/j.aquatox.2015.07.008 · Cited by 28
Wang, Z., Trope, C. G., Suo, Z., Trøen, G., Yang, G., Nesland, J. M., & Holm, R. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-308 · Cited by 31
“Responsive to DNA damage, 14-3-3σ expression is induced in a p53-dependent manner [10-12].”
BackgroundImproving the selectivity of cancer treatments by interfering with cell response pathways
Damia, G. L. M., & Broggini, M. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.07.020 · Cited by 29
“In many cancer cells, the re-introduction of a wild-type (wt)-p53 leads to growth arrest and/or apoptosis [53–55], although the presence of multiple alterations in other genes might mask or make a complete response unlikely with this kind of treatment alone.”
BackgroundLorenz, L. D., Cardona, J. R., & Lambert, P. F. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003717 · Cited by 28
“Activation of ATM as a consequence of DNA damage can lead to subsequent phosphorylation of p53 and consequently growth arrest, senescence and apoptosis (reviewed in [78]).”
BackgroundMechanisms of 5‐azacytidine (5AzC)‐induced toxicity in the rat foetal brain
Ueno, M., Katayama, K., Nakayama, H., & Doi, K. (2002) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2002.00225.x · Cited by 31
Chen, S., Lin, T., Tseng, Y., Tu, C.-H., Lui, T., Huang, S., Hsieh, L., & Li, Y. (2018) · Cancer Medicine · doi:10.1002/cam4.1658 · Cited by 27
Kobayashi, G., Sentani, K., Hattori, T., Yamamoto, Y., Imai, T., Sakamoto, N., Kuraoka, K., Oue, N., Sasaki, N., Taniyama, K., et al. (2018) · Human Pathology · doi:10.1016/j.humpath.2018.09.001 · Cited by 31
“The tumor suppressor p53 is a key regulator of the DNA damage response [24], and it also coexpressed with claspin.”
BackgroundHan, J., Heo, K., & Myung, C. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15631 · Cited by 30
“The findings of this current study show that CIAPIN1 accelerates VSMC proliferation, migration and neointima formation in vascular injury through negatively regulating tumour protein p53 (p53) transcription, as a functional cell cycle regulator (Lakin & Jackson, 1999).”
BackgroundA dual role of RBM42 in modulating splicing and translation of CDKN1A/p21 during DNA damage response
Ben‐Oz, B. M., Machour, F. E., Nicola, M., Argoetti, A., Polyak, G., Hanna, R., Kleifeld, O., Mandel‐Gutfreund, Y., & Ayoub, N. (2023) · Nature Communications · doi:10.1038/s41467-023-43495-6 · Cited by 29
Metadata
- Authors
- Lakin, N. D., & Jackson, S. P.
- Affiliations
- University of Cambridge (GB)
- ORCID
- Jackson, Stephen P
- Venue
- Oncogene
- Published
- 1999-12-13
- Volume
- 18
- Issue
- 53
- Pages
- 7644-7655
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2007935491
- Cited by
- 987
- References
- 128
- Citations by year
- 2026: 18 · 2025: 29 · 2024: 30 · 2023: 54 · 2022: 57 · 2021: 46 · 2020: 46 · 2019: 33 · 2018: 40 · 2017: 43 · 2016: 34 · 2015: 33 · 2014: 28 · 2013: 23 · 2012: 28
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, DNA damage response, p53 activation, post-translational modification, phosphorylation, dephosphorylation, acetylation, ionizing radiation, ultraviolet radiation, methyl methanesulfonate, cell cycle arrest, apoptosis, DNA repair, transcriptional activation, hypoxia
- MeSH terms
- Adenosine Triphosphatases, Animals, DNA Damage, DNA Helicases, DNA-Binding Proteins, Humans, Nuclear Proteins, Protein Processing, Post-Translational, Proto-Oncogene Proteins, Signal Transduction, Trans-Activators, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Tumor Suppressor Proteins, Saccharomyces cerevisiae Proteins, Proto-Oncogene Proteins c-mdm2, DNA-Activated Protein Kinase, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.